Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CASR | P41180 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14809829 | 0.96 | CASR (0.36) | CASR | |
| Alanine SCHEMBL6724963 | 0.94 | CASR (0.34) | CASR | |
| Histidine SCHEMBL7686781 | 0.87 | SLC7A5 (0.46) | — | |
| Histidine SCHEMBL6426902 | 0.86 | SLC7A5 (0.40) | — | |
| Histidine SCHEMBL6426901 | 0.86 | SLC7A5 (0.40) | — | |
| Histidine SCHEMBL668807 | 0.86 | SLC7A5 (0.40) | — | |
| Histidine SCHEMBL28805947 | 0.86 | SLC7A5 (0.40) | — | |
| Lysine SCHEMBL18297991 | 0.86 | GSR (0.41) | CASR | |
| Histidine SCHEMBL6947394 | 0.85 | CYP3A4 (0.32) | CASR | |
| Histidine SCHEMBL6724968 | 0.84 | SLC7A5 (0.38) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108586615-B | Modified IgG4 bispecific antibodies of sequence symmetry | UCB生物制药有限责任公司 | 2022-03-08 | — | — | CN | claimed |
| CN-105859876-B | Improved IgG4 class antibodies | UCB医药有限公司 | 2021-04-02 | — | — | CN | claimed |
| EP-3670531-A1 | ASYMMETRIC, MODIFIED IGG4 BISPECIFIC ANTIBODIES | UCB Biopharma SRL (BE) | 2020-06-24 | — | — | EP | claimed |
| US-20200157204-A1 | Antibodies of the Class IGG4 | UCB Biopharma SRL (BE) | 2020-05-21 | — | — | US | claimed |
| EP-3156416-B1 | SEQUENCE SYMMETRIC MODIFIED IGG4 BISPECIFIC ANTIBODIES | UCB BIOPHARMA SPRL (BE) | 2019-11-20 | — | — | EP | claimed |
| CN-108586615-A | The IgG4 bispecific antibodies of the modification of sequence symmetry | UCB医药有限公司 | 2018-09-28 | — | — | CN | claimed |
| CN-104321341-B | Modified IgG4 bispecific antibodies of sequence symmetry | UCB医药有限公司 | 2018-05-22 | — | — | CN | claimed |
| US-9902768-B2 | Sequence asymmetric modified IgG4 bispecific antibodies | UCB BIOPHARMA SPRL (BE) | 2018-02-27 | — | — | US | claimed |
| EP-2606063-B1 | IMPROVED ANTIBODIES OF THE CLASS IGG4 | UCB BIOPHARMA SPRL (BE) | 2017-05-17 | — | — | EP | claimed |
| EP-3156416-A1 | SEQUENCE SYMMETRIC MODIFIED IGG4 BISPECIFIC ANTIBODIES | UCB Biopharma SPRL (BE) | 2017-04-19 | — | — | EP | claimed |
| CN-105859876-A | Improved antibodies of the class IgG4 | UCB医药有限公司 | 2016-08-17 | — | — | CN | claimed |
| EP-2817332-B1 | SEQUENCE SYMMETRIC MODIFIED IGG4 BISPECIFIC ANTIBODIES | UCB BIOPHARMA SPRL (BE) | 2016-07-20 | — | — | EP | claimed |
| CN-103097410-B | Improved IgG4 class antibodies | UCB PHARMA S.A. (BE) | 2016-06-01 | — | — | CN | claimed |
| EP-2817333-A1 | SEQUENCE SYMMETRIC MODIFIED IGG4 BISPECIFIC ANTIBODIES | UCB Pharma, S.A. (BE) | 2014-12-31 | — | — | EP | claimed |
| EP-2817332-A1 | SEQUENCE SYMMETRIC MODIFIED IGG4 BISPECIFIC ANTIBODIES | UCB Pharma S.A. (BE) | 2014-12-31 | — | — | EP | claimed |
| US-20130323236-A1 | Antibodies of the Class IGG4 | UCB PHARMA S.A. (BE) | 2013-12-05 | — | — | US | claimed |
| WO-2013124451-A1 | SEQUENCE SYMMETRIC MODIFIED IGG4 BISPECIFIC ANTIBODIES | UCB PHARMA S.A. (BE) | 2013-08-29 | — | — | WO | claimed |
| WO-2013124450-A1 | SEQUENCE SYMMETRIC MODIFIED IGG4 BISPECIFIC ANTIBODIES | UCB PHARMA S.A. (BE) | 2013-08-29 | — | — | WO | claimed |
| CN-108586615-B | Modified IgG4 bispecific antibodies of sequence symmetry | UCB生物制药有限责任公司 | 2022-03-08 | — | — | CN | disclosed |
| WO-2012022982-A2 | IMPROVED ANTIBODIES OF THE CLASS IGG4 | UCB PHARMA S.A. (BE) | 2012-02-23 | — | — | WO | disclosed |